Listen to the new episode of the Clinical Trial Files podcast, where Karin Avila, Taymeyah Al-Toubah and Thomas Wood of Fast Data Science chat about AI and NLP in pharma, the Clinical Trial Risk Tool, what impact AI can make in clinical trials. This episode commemorates Alan Turing’s 113rd birthday on 23 June 2025.
The group chatted about how a team of data scientists together with clinical professionals can be much greater than the sum of its parts, and what traditional machine learning, statistics, and generative AI can achieve in the clinical research field.
Thomas Wood also discussed the thinking behind Fast Data Science’s flagship product, the Clinical Trial Risk Tool, and why and how this tool came to exist and how it’s helping clinical researchers validate protocols. Karin and Taymeyah told us about the exciting developments in AI that they are seeing in clinical research.
The Clinical Trial Files podcast is organised by Karin Avila, Taymeyah Al-Toubah, and Roberto Torres. You can listen below on Spotify:
You can find the Clinical Trial Files podcast episode on
Dive into the world of Natural Language Processing! Explore cutting-edge NLP roles that match your skills and passions.
Explore NLP Jobs
Thomas Wood presents the Clinical Trial Risk Tool before the November meeting of the Clinical AI Interest Group at Alan Turing Institute The Clinical AI Interest group is a community of health professionals from a broad range of backgrounds with an interest in Clinical AI, organised by the Alan Turing Institute.
Fast Data Science will appear at Ireland’s Expert Witness Conference on 20 May 2026 in Dublin On 20 May 2026, La Touche Training is running the Expert Witness Conference 2026, at the Radisson Blu Hotel, Golden Lane, Dublin 8, Ireland. This is a full-day event combining practical workshops and interactive sessions, aimed at expert witnesses and legal professionals who want to enhance their expertise. The agenda covers critical topics like recent developments in case law, guidance on report writing, and techniques for handling cross-examination.
Guest post by Alex Nikic In the past few years, Generative AI technology has advanced rapidly, and businesses are increasingly adopting it for a variety of tasks. While GenAI excels at tasks such as document summarisation, question answering, and content generation, it lacks the ability to provide reliable forecasts for future events. GenAI models are not designed for forecasting, and along with the tendancy to hallucinate information, the output of these models should not be trusted when planning key business decisions. For more details, a previous article on our blog explores in-depth the trade-offs of GenAI vs Traditional Machine Learning approaches.
What we can do for you
